SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Genentech Inc.

Headquarters : 1 DNA Way South San Francisco, CA 94080-4990 United States of America United States of America
Job offers, investor relations : web www.gene.com tel. 650-225-1000 email: investor.relations@gene.com stock : DNA analytics

Brands

name
click to compare prices
Genentech
Tanox
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Genentech Inc. , group Roche Holding and subsidiaries

Jobs -4% /1998 Pollution 3 Fraud 6 Offshore 2 Sales 31 Bn $.€ /year Profit 15 Bn $.€ /1998 Wage 1404 *min. Influence 10 Infocom 1
[click on the rating for the method or on the number for the data]
year
business
source
2004The world's second largest biotechnology group.Les Echos
» More business descriptions and market shares for Genentech Inc..

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2003Hellman, Susan
See the photo of: Hellman, Susan Chairman;
2003Juelsgaard, Stephen
See the photo of: Juelsgaard, Stephen Vice-president;
2003Lavigne Jr, Louis
See the photo of: Lavigne Jr, Louis Chief Financial Officer; salary: 0,81 million US$; stock-options: 14,27 million US$;
2003Potter, Myrtle
See the photo of: Potter, Myrtle Chairman; salary: 1,74 million US$; stock-options: 7,8 million US$;
1999Humer, F B
See the photo of: Humer, F B Director;
1998Levinson, Arthur D
See the photo of: Levinson, Arthur D Chief Executive Officer; salary: 1,08 million US$;
Forbes
» More executive salaries for Genentech Inc.
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2003
6226
2002
5252
1998
3389
» More restructuring at Genentech Inc.
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 3 informations, access to subscribers
» More restructuring at Genentech Inc.
» Layoff plans and labour conditions in 2007

  • Subsidy

  • Advertising & marketing

year  salesincome buybacksource
2007   2billion US$
2005   4billion US$The Street.com
2004   4,6   billion US$
2003   2,80,56   billion US$
2002   2,250,06   billion US$
2001   1,820,15   billion US$
2000   1,65-0,02   billion US$
1998   1,060,18   billion US$
» More financial data for Genentech Inc.
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 8 informations, access to subscribers
» More financial data for Genentech Inc.
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 97 thousand US$ : US President, Congress, Senate translateCenter for Responsive Politics
» More influence from Genentech Inc.
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 2 informations, access to subscribers
» More influence from Genentech Inc.
» Influence in 2007
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS